Many patients receive prescription opioids during treatment for opioid addiction

February 23, 2017

More than two in five people receiving buprenorphine, a drug commonly used to treat opioid addiction, are also given prescriptions for other opioid painkillers - and two-thirds are prescribed opioids after their treatment is complete, a new Johns Hopkins Bloomberg School of Public Health study suggests.

The findings, published Feb. 23 in the journal Addiction, demonstrate the need for greater resources devoted to medication-assisted treatment, a common clinical tool to address the epidemic.

The idea behind medication-assisted treatment is that are given low-dose opioids that produce some of the effects of opioids while staving off physical withdrawal symptoms. The low-dose opioids produce weaker effects than drugs such as oxycodone or heroin, which come with the risk of addiction and overdose. With medication-assisted treatment, rigorous studies have shown that patients are more able to remain healthy and productive members of society.

Historically, the most common drug to treat opioid use disorders has been methadone, though over the past 15 years, , a shorter-acting opioid similar to methadone, has been increasingly used instead. For this study, the researchers looked at prescriptions for buprenorphine and Suboxone, a combination of buprenorphine and naloxone, an anti-overdose medication. Rather than requiring a special clinic like methadone does, buprenorphine can be prescribed in a doctor's office, making it accessible to more patients.

"Policymakers may believe that people treated for opioid addiction are cured, but people with substance use disorders have a lifelong vulnerability, even if they are not actively using," says study leader G. Caleb Alexander, MD, MS, an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health and the co-director of the School's Center for Drug Safety and Effectiveness. "Our findings highlight the importance of stable, ongoing care for these patients."

Increases in prescription opioid use over the past two decades have led to an epidemic of addiction, injuries and deaths in the United States. In 2013, providers wrote nearly 250 million opioid prescriptions, enough to supply every adult in the United States with a bottle of pills. While it is sometimes appropriate for a patient to receive a prescription opioid during medication-assisted treatment - patients who are in acute pain from a major trauma or surgery may require short-term prescription opioids in addition to their medication-assisted treatment - the researchers say they are concerned to see such high rates of combined use of these products. This pattern suggests that many patients do not have well-coordinated treatment for opioid use disorders and chronic pain, which could lead to higher rates of relapse or overdose, Alexander says.

For their study, Alexander and his colleagues examined pharmacy claims for more than 38,000 new buprenorphine users who filled prescriptions between 2006 and 2013 in 11 states. They looked at non-buprenorphine opioid prescriptions before, during, and after each patient's first course of , which typically lasted between one to six months. Even though there are no universally agreed-upon guidelines regarding the optimal length of treatment, most people discontinued buprenorphine within three months.

They found that 43 percent of patients who received buprenorphine filled an opioid prescription during treatment and 67 percent filled an opioid prescription during the 12 months following buprenorphine treatment. Most patients continued to receive similar amounts of opioids before and after buprenorphine treatment.

Because the study data lacked information on patients' use of illegal opioids like heroin, the results likely underestimate the proportion of patients using opioids during and after buprenorphine treatment. "The statistics are startling," says Alexander, "but are consistent with studies of patients treated with methadone showing that many patients resume opioid use after treatment."

Recent federal efforts have tried to improve the availability of medication-assisted treatment, so providing ongoing professional education and support to these providers will be important.

"Unlike methadone, buprenorphine can be prescribed for opioid use disorders in primary care, so it is an important treatment option for clinicians and patients to have," says study co-author Matthew Daubresse, a doctoral student in the Department of Epidemiology at the Bloomberg School. "But many patients, especially those with shorter lengths of treatment, appear to be continuing to use prescription opioids during and after buprenorphine treatment. We need to find better ways to keep patients engaged in long-term , and these efforts couldn't be more urgent given how many Americans continue to die or get injured from ."

"Non-Buprenorphine Opioid Utilizations Among Patients Using Buprenorphine" was written by Matthew Daubresse, Brendan Saloner, Harold A. Pollack and G. Caleb Alexander.

Explore further: Study examines opioid agonist therapy use in Medicare patients

Related Stories

Study examines opioid agonist therapy use in Medicare patients

July 20, 2016
Few Medicare enrollees appear to be receiving buprenorphine-naloxone, the only opioid agonist therapy for opioid addiction available through Medicare Part D prescription drug coverage, according to a study published online ...

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Researchers developing mobile app for opioid detoxification

February 7, 2017
In the midst of the opioid epidemic, an estimated 1.5 million Americans seek treatment annually in an effort to avoid the life-threatening effects of opioid use disorder and improve their quality of life.

For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

October 20, 2014
For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the ...

Methadone increases death risk in first four weeks of treatment for opioid dependence

September 16, 2015
Patients who start treatment for dependence on opioids are five times as likely to die in the first four weeks when they are prescribed the most commonly used treatment, methadone, than with an alternative treatment, buprenorphine, ...

Team reports on study of waitlisted opioid-dependent adults

December 21, 2016
In rural states like Vermont, opioid-dependent adults desperate for treatment often find themselves stuck on a wait list, sometimes for eight months or more, increasing their risk of continuing to use illicit opioids, contract ...

Recommended for you

Medical students need training to prescribe medical marijuana

September 15, 2017
Although 29 states and the District of Columbia allow marijuana use for medical purposes, few medical students are being trained how to prescribe the drug. Researchers at Washington University School of Medicine in St. Louis ...

Protein links alcohol abuse and changes in brain's reward center

September 8, 2017
When given access to alcohol, over time mice develop a pattern similar to what we would call "problem drinking" in people, but the brain mechanisms that drive this shift have been unclear. Now a team of UC San Francisco researchers ...

11 minutes of mindfulness training helps drinkers cut back

August 24, 2017
Brief training in mindfulness strategies could help heavy drinkers start to cut back on alcohol consumption, finds a new UCL study.

Marijuana use amongst youth stable, but substance abuse admissions up

August 15, 2017
While marijuana use amongst youth remains stable, youth admission to substance abuse treatment facilities has increased, according to new research from Binghamton University, State University of New York.

Report reveals underground US haven for heroin, drug users

August 8, 2017
A safe haven where drug users inject themselves with heroin and other drugs has been quietly operating in the United States for the past three years, a report reveals.

Regular energy drink use linked to later drug use among young adults

August 8, 2017
Could young adults who regularly consume highly caffeinated energy drinks be at risk for future substance use? A new study by University of Maryland School of Public Health researchers, published in the journal Drug and Alcohol ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Feb 23, 2017
Opioid addiction is cured by 250mg healthy adult male facial skin surface lipid p.o. 1 time, w/out withdrawal symptoms. Pheromone collection & administrative staff should wear supplied air respirators. Oscillating fans (w/ dilute ethanol mist) should run to break up pheromone plumes emitted into the air by stockpiles of collected paternal facial skin surface sebaceous lipid pheromone. Skin surface pheromone is usually transferred by kissing. Isolate recovering addicts 40 days. Illuminate skin surface pheromone collections with germicidal UV. Store under fume hood. Use hermetically sealed packaging w/activated charcoal dunnage to control airborne emissions which cause distrust, arrogance, suspicion & worse. No kissing as osculation partners become artificially jealous every time.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.